Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    yesterday
    Change Detected
    Summary
    A minor interface/version update is reflected by changing the displayed “Revision” from v3.5.2 to v3.5.3, without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:21:37.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:43.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision (v3.5.0) was added to the record history and an older revision (v3.4.3) was removed.
    Difference
    0.1%
    Check dated 2026-03-20T03:28:15.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the record history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:27.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new version entry v3.4.2 was added to the record history, and the previous entry v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:12.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The history shows an internal release update with the addition of revision v3.4.1 and removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:15:10.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.